Atara Biotherapeutics, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2012 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Atara Biotherapeutics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q4 2012 to Q3 2024.
  • Atara Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $6.42M, a 42.4% decline year-over-year.
  • Atara Biotherapeutics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $31.1M, a 33.6% decline year-over-year.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $45.4M, a 15.7% decline from 2022.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $53.8M, a 0.05% decline from 2021.
  • Atara Biotherapeutics, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $53.9M, a 4.9% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $31.1M $6.42M -$4.72M -42.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $35.8M $6.34M -$6.22M -49.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $42M $8.4M -$3.37M -28.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $45.4M $9.93M -$1.44M -12.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-28
Q3 2023 $46.8M $11.1M -$2.88M -20.5% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $49.7M $12.6M -$1.57M -11.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $51.3M $11.8M -$2.57M -17.9% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $53.8M $11.4M -$2.67M -19% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-28
Q3 2022 $56.5M $14M +$261K +1.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-01
Q2 2022 $56.2M $14.1M +$310K +2.25% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $55.9M $14.3M +$2.07M +16.8% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $53.9M $14M +$2.52M +21.9% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-08
Q3 2021 $51.3M $13.8M +$507K +3.83% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 $50.8M $13.8M -$141K -1.01% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 $51M $12.3M -$376K -2.97% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $51.4M $11.5M -$570K -4.72% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-08
Q3 2020 $51.9M $13.3M +$1.1M +9.08% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $50.8M $13.9M -$1.25M -8.24% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $52.1M $12.6M +$375K +3.06% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q4 2019 $51.7M $12.1M +$2.52M +26.4% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-28
Q3 2019 $49.2M $12.2M +$2.9M +31.3% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 $46.3M $15.2M +$7.2M +90.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-05
Q1 2019 $39.1M $12.3M +$5.26M +74.9% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 $33.8M $9.55M +$3.46M +56.7% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-01
Q3 2018 $30.4M $9.25M +$3.25M +54.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 $27.1M $8M +$2.34M +41.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $24.8M $7.01M +$1.67M +31.2% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 $23.1M $6.1M +$4.44M +268% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-27
Q3 2017 $18.7M $6M +$731K +13.9% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 $17.9M $5.66M +$521K +10.1% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-01
Q1 2017 $17.4M $5.35M +$623K +13.2% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-08
Q4 2016 $16.8M $1.66M -$1.31M -44.1% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-26
Q3 2016 $18.1M $5.27M +$3.04M +136% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-09
Q2 2016 $15.1M $5.14M +$2.57M +99.9% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-07
Q1 2016 $12.5M $4.72M +$2.24M +90.3% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-04
Q4 2015 $10.3M $2.97M -$2.81M -48.6% Oct 1, 2015 Dec 31, 2015 10-K 2018-02-27
Q3 2015 $13.1M $2.23M +$1.75M +360% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-04
Q2 2015 $11.3M $2.57M +$2.05M +390% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 $9.27M $2.48M -$834K -25.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 $10.1M $5.77M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-09
Q3 2014 $486K +$147K +43.4% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-06
Q2 2014 $524K Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 $3.32M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-11
Q3 2013 $339K Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-12
Q4 2012 $292K Aug 22, 2012 Dec 31, 2012 10-K 2015-02-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.